Growth Metrics

Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments (2016 - 2026)

Jazz Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 12 years, most recently at $180.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 37.93% year-over-year to $180.0 million; the TTM value through Dec 2025 reached $1.4 billion, up 60.95%, while the annual FY2025 figure was $1.4 billion, 60.95% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $180.0 million at Jazz Pharmaceuticals, down from $400.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $760.0 million in Q1 2021 and troughed at $20.0 million in Q3 2023.
  • A 5-year average of $279.2 million and a median of $290.0 million in 2024 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 1675.0% in 2024 and later plummeted 37.93% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $335.0 million in 2021, then plummeted by 82.09% to $60.0 million in 2022, then soared by 316.67% to $250.0 million in 2023, then grew by 16.0% to $290.0 million in 2024, then plummeted by 37.93% to $180.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for JAZZ at $180.0 million in Q4 2025, $400.0 million in Q3 2025, and $470.0 million in Q2 2025.